ExL Pharma's Leading European Digital Marketing and Public Relations Conferences to Be Hosted at Bayer Schering Pharma Corporate Headquarters, March 29-30th, 2010
11/19/2009 10:33:24 AM
More...
|
Compugen Ltd. (CGEN), Bayer Schering Pharma (JOBS) to Team up on Antibody Target Drug
10/13/2009 6:55:06 AM
More...
|
MorphoSys AG Announces Clinical Milestone in Cancer Program with Bayer Schering Pharma
9/8/2009 2:32:09 PM
More...
|
Seattle Genetics, Inc. (SGEN) Achieves Milestone Under Antibody-Drug Conjugate Collaboration With Bayer Schering Pharma
9/8/2009 8:49:45 AM
More...
|
Algeta Signs $800 Million Global Agreement With Bayer Schering Pharma (JOBS) for Development and Commercialization of Alpharadin for Bone Metastases
9/3/2009 7:04:21 AM
More...
|
Celera Corporation (CRA) Grants License to Bayer Schering Pharma for Cancer-Related Targets
6/29/2009 7:53:31 AM
More...
|
Fresenius Kabi AG And Bayer Schering Pharma Enter into a Research, Development and License Agreement Regarding HESylation(R) Technology
5/18/2009 11:50:51 AM
More...
|
UK's NICE Recommends Bayer Schering Pharma's Drug Xarelto
3/5/2009 7:37:11 AM
More...
|
Affimed Therapeutics AG Joins the Molecular Imaging Technology Initiative
2/9/2009 1:05:25 PM
More...
|
Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma; Micromet to Get $ 6 Million
1/12/2009 6:39:01 AM
More...
|
|